RSV Vaccines in Adults: A Risk-Based Approach

CCO Infectious Disease Podcast

English - December 27, 2023 19:17 - 9 minutes - 8.95 MB
Courses Education Science Life Sciences hiv covid-19 cme hepatitis b hbv id medical education coronavirus hepatitis c hcv Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: How to Implement Earlier Hepatitis B and Hepatitis Delta Screening

Next Episode: Long-Acting PrEP: Strategies to Support PrEP Persistence and Reengagement

In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including:

Current Advisory Committee on Immunization Practices recommendationsRisk factors associated with severe RSV disease, including RSV-related hospitalizationsApproach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities Health disparities related to RSV vaccinesConsiderations for a risk-based approach, rather than age alone, to determine vaccine candidacy

Faculty:

Angela Branche, MD
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Link to full program:
https://bit.ly/3nb25xe

Link to downloadable slides:
https://bit.ly/3TsXym5